Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $171000.0.

  • Caribou Biosciences' Change in Receivables rose 47173.91% to $171000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $122000.0, marking a year-over-year increase of 10833.9%. This contributed to the annual value of -$458000.0 for FY2024, which is 74507.04% down from last year.
  • Caribou Biosciences' Change in Receivables amounted to $171000.0 in Q3 2025, which was up 47173.91% from -$17000.0 recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Change in Receivables registered a high of $2.8 million during Q2 2021, and its lowest value of -$2.2 million during Q3 2021.
  • Its 5-year average for Change in Receivables is -$98842.1, with a median of -$46000.0 in 2024.
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 68447.37% in 2021, then surged by 51797.47% in 2023.
  • Caribou Biosciences' Change in Receivables (Quarter) stood at $127000.0 in 2021, then crashed by 481.89% to -$485000.0 in 2022, then plummeted by 77.32% to -$860000.0 in 2023, then soared by 116.86% to $145000.0 in 2024, then rose by 17.93% to $171000.0 in 2025.
  • Its Change in Receivables stands at $171000.0 for Q3 2025, versus -$17000.0 for Q2 2025 and -$177000.0 for Q1 2025.